University Hospitals Cleveland Medical Center

Open enrollment with a later-stage pipeline tilt

According to ClinicalTrials.gov-derived indexes, University Hospitals Cleveland Medical Center sits in the top decile of US sponsors by registered trial count (#142 of 15,742 sponsors by registered trial count).

230 total trials 42 currently recruiting 154 completed later-stage tilt top decile by trial count

University Hospitals Cleveland Medical Center: 230 sponsored US clinical trials, 42 recruiting.

University Hospitals Cleveland Medical Center sponsors 230 registered US clinical trials on ClinicalTrials.gov, 42 of them currently recruiting, and 154 completed. 48 of these trials are in Phase 3-4 (later-stage) and 27 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Bipolar Disorder, with 6 trials.

Top-decile sponsor footprint

University Hospitals Cleveland Medical Center ranks in the top decile of sponsors by registered trial count (#142 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Trial completion reliability score

D 52/100

154 of 181 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (85.1%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.

Open and recent trials

230 total, page 1 of 5

RECRUITING Phase 4

Deutetrabenazine Treatment for Tardive Dyskinesia in Intellectual/Developmental Disabilities

NCT06997198

RECRUITING

Rectus Abdominis Detrusor Myoplasty for Urinary Retention

NCT07379814

RECRUITING NA

Baby Steps to Care

NCT07499648

RECRUITING NA

Direct Comparison of Cardiac CT With TEE to Evaluate Watchman FLX LAA Occluder Device Characteristics

NCT06523166

RECRUITING NA

POP SINGER Pilot Study

NCT07450131

RECRUITING NA

Sternal Plating High Risk

NCT06660186

RECRUITING NA

Application of a Prediction Model for Directing Antibiotic Use in the Treatment of Urinary Tract Infection in an Ambulatory Setting

NCT06976125

RECRUITING NA

Using Mindfulness in an Enhanced Recovery After Surgery Protocol to Support Recovery After Colorectal Surgery

NCT07026786

RECRUITING NA

Transverse Tibial Transport for Chronic Limb-Threatening Ischemia (CLTI)

NCT07175129

RECRUITING NA

Utilizing Community Health Workers as Diabetes Technology Coaches for Children With Type 1 Diabetes Using Automated Insulin Delivery

NCT07154251

RECRUITING NA

Microlearning-Based Health Education for Ambulatory Surgery Patients

NCT07221435

RECRUITING NA

Diagnosis and Treatment of Urinary Tract Infection Using DNA Polymerase Chain Reaction Versus Urine Culture

NCT06808451

RECRUITING Phase 4

Patient Preference and Long-term Outcomes in Persistent Spinal Pain Syndrome: A Prospective Study Comparing Spinal Cord Stimulation to Intrathecal Drug Delivery.

NCT07091123

RECRUITING NA

Contrast and Anesthetic Level With Lumbar Erector Spinae Plan (ESP) Block

NCT07174440

RECRUITING

Gender Affirming Vaginoplasty With Tubularized Augmented Peritoneal Cap (TAPCap) Utilizing Fish Skin Xenograft (Kerecis™)

NCT07286123

RECRUITING

Evaluating the Real World Performance of an AI Based Lung Nodule Detection Tool

NCT06597968

RECRUITING

Role of Phosphatidylethanol in Predicting Perioperative Outcomes of Admitted Patients at UHCMC

NCT06864819

RECRUITING NA

BELIEVE Trial: Bulking vErsus sLing for Treating Stress Urinary IncontinEnce at the Time of Vaginal prolapsE Repair (BELIEVE)

NCT06754046

RECRUITING

Use of Thermal Imaging Camera to Assess Perfusion Before and After Vascular Intervention

NCT06544135

RECRUITING NA

Hysteroscopic Resection Versus Manual Vacuum Aspiration for Early Pregnancy

NCT07088510

RECRUITING Phase 4

Magnesium as an Adjuvant Agent for Postoperative Pain

NCT05947760

RECRUITING Phase 4

Postpartum Vaginal Estrogen for Breastfeeding Patients

NCT05457972

RECRUITING NA

Innovating Physical Therapy: A Pilot Study on Band Connect's Impact on Compliance, Satisfaction, and Revenue

NCT06733480

RECRUITING NA

Acupuncture First for IC/BPS

NCT06366269

RECRUITING Phase 2

Milk Thistle Clinical Trial in Pediatric NAFLD

NCT06477146

RECRUITING Phase 4

Pre-operative Polyethylene Glycol 3350 for Minimally Invasive Urogynecologic Surgery

NCT06159777

RECRUITING Phase 4

Seizure Rescue Medication (RM) as Part of a Comprehensive Epilepsy Self-management Package of Care

NCT06346262

RECRUITING NA

MRI in Transcatheter Aortic Valve Replacement Patients

NCT05603026

RECRUITING NA

Home BP Monitoring

NCT05552547

RECRUITING Phase 4

Outpatient Antibiotics Following Previable Rupture of Membranes (pPPROM) Between 18 0/7 and 22 6/7 Weeks Gestational Age

NCT05345457

RECRUITING Phase 4

Development of Predictive Psoriasis Response Endotypes Using Single Cell Transcriptomics

NCT05270733

RECRUITING NA

Mediterranean Diet vs no Dietary Intervention for Improving Signs and Symptoms of Psoriasis in Patients Treated With Anti-IL-17 or Anti-IL-23 Inhibitors

NCT06399432

RECRUITING NA

Patient Recall After Orthopedic Trauma

NCT05616312

RECRUITING NA

Analysis of Red Blood Cell Integrity and Efficiency of Recovery Using a Novel Surgical Sponge-Blood Recovery Device (ProCell)

NCT05545930

RECRUITING NA

Project 3: ACHIEVE- CHD

NCT05918380

RECRUITING NA

Muscle O2 Saturation and Hemoglobin Levels During Rehabilitation From Arthroscopic Surgery

NCT05488054

RECRUITING NA

Patient-Centered Outcomes in the Surgical Treatment of Uterovaginal Prolapse

NCT05063331

RECRUITING NA

Comparison of Partial Rotator Cuff Repair vs. Superior Capsular Reconstruction for Irreparable Rotator Cuff Tears

NCT04742452

RECRUITING

Human Skin and Gut Mycobiome and Bacteriome Comprehensive Registry

NCT05196061

RECRUITING

Attentional Biases, Reward Sensitivity, and Cognitive Control in Adults With Bipolar Disorder

NCT03829787

RECRUITING

Sickle Cell Disease Biofluid Chip Technology (SCD BioChip)

NCT02824471

RECRUITING

Community Benefit of No-charge Calcium Score Screening Program

NCT04075162

ACTIVE NOT RECRUITING NA

iHERO Study: Insurance, Health and Economic Resources Online for Emerging Adults With Type 1 Diabetes

NCT06348160

ACTIVE NOT RECRUITING NA

Cyclic Versus Continuous Sacral Neuromodulation for LUTS

NCT06170450

ACTIVE NOT RECRUITING Phase 1

Impact of Mesenchymal Stem Cells in Knee Osteoarthritis

NCT03477942

NOT YET RECRUITING NA

Surgical Ergonomics in OBGYN

NCT07609420

NOT YET RECRUITING Phase 4

OMT for Adhesive Capsulitis

NCT07497737

NOT YET RECRUITING NA

Identification of Depressive and Anxiety Symptoms Among a Sample of Emergency Department Patients Using Artificial Intelligence (AI) Technology

NCT06473558

NOT YET RECRUITING Phase 1

Escalating Doses of Memantine in Down Syndrome (MEDS-123)

NCT07531940

COMPLETED NA

Efficacy of Cotton as a Dampener for Vibration Anesthetic Device

NCT06916468

Page 1 of 5 Next →

Phase Distribution

PhaseTrial count
Phase 1 14
Phase 2 13
Phase 3 16
Phase 4 32

Where University Hospitals Cleveland Medical Center enrollment is open (later-stage tilt)

42 recruiting of 230 indexed (18% open); 154 completed (67%).

Phase mix: 48 late (III/IV) vs 27 early (I/II) (later-stage heavy).

Top condition: Bipolar Disorder (6 trials), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

University Hospitals Cleveland Medical Center: open-pipeline peers nationwide

Peers matched on 230 registered trials and 18% open enrollment, not the therapeutic-area sidebar.

University Hospitals Cleveland Medical Center sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 050100150200250 10%12%14%16%18%20% Total trials Recruiting share University Hospitals Cleveland Medical CenterBrown UniversityUniversity of IowaGeorgetown UniversityHenry Ford Health SystemBurke Medical Research InstituteGrand Valley State UniversityImunonInventisBio Co.
University Hospitals Cleveland Medical Center sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

University Hospitals Cleveland Medical Center sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 230 trials (± recruiting share)

Sponsors near 18% open enrollment (± trial volume)

What to do with this University Hospitals Cleveland Medical Center page

230 registered trials is a research-attention snapshot, not an endorsement of University Hospitals Cleveland Medical Center or any single study.

  • 42 of University Hospitals Cleveland Medical Center's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Bipolar Disorder is the condition University Hospitals Cleveland Medical Center studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Bipolar Disorder trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

University Hospitals Cleveland Medical Center pipeline card: 230 registered trials from official public datasets.Report a data error.